Published in Lancet on October 10, 1987
Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A (1990) 7.19
Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol (1989) 2.40
Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax (1989) 1.58
Two sisters with ANCA positive vasculitis. Ann Rheum Dis (1993) 1.40
Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am J Pathol (1991) 0.94
Anti-neutrophil cytoplasmic antibodies and vasculitis. Postgrad Med J (1990) 0.87
Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome. Ann Rheum Dis (1991) 0.85
Production of human monoclonal antibodies to myeloperoxidase. Immunology (1992) 0.81
Microscopic polyarteritis: clinical features and treatment. Postgrad Med J (1989) 0.75
Wegener's granulomatosis. West J Med (1989) 0.75
No escape: HIV transmission in jail. BMJ (1993) 3.91
Revised guidelines for HIV infected health care workers. BMJ (1993) 3.16
Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet (2001) 2.92
Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ (1995) 2.66
Inside methodology: HIV surveillance in prisons. AIDS (1994) 2.39
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature (1981) 2.10
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Uptake of confidential, named HIV testing in Scottish prisons. Lancet (1992) 2.01
Prisoners' uptake of confidential, named HIV testing. Lancet (1992) 1.99
A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev (1979) 1.91
Wegener's granulomatosis and the heart. Br Heart J (1994) 1.82
A live human B-cell activator operating in isolation of other cellular influences. Scand J Immunol (1979) 1.54
No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49
Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland. Int J STD AIDS (1997) 1.48
Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM (1999) 1.47
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy. Nephrol Dial Transplant (1995) 1.42
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Recent non-sterile inoculation injuries to dental professionals in the Lothian region of Scotland. Br Dent J (1994) 1.39
Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay. Immunology (1979) 1.39
Increased expression of the CD45RO (memory) antigen on T cells in HIV-infected children. AIDS (1991) 1.37
The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods (1984) 1.21
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect Immun (1999) 1.15
Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS (1996) 1.11
Second anonymous HIV surveillance in Saughton Prison, Edinburgh: prisoners give a lead to other heterosexuals on being HIV tested. AIDS (1993) 1.10
Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev (1981) 1.05
Drugs in British prisons. Policies need outside scrutiny if they are to do more good than harm. BMJ (1998) 1.05
Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med (1990) 1.04
Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J (1992) 1.02
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. Int J STD AIDS (1994) 0.99
Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood (1980) 0.97
Method used to identify previously undiagnosed infections in the HIV outbreak at Glenochil prison. Epidemiol Infect (1999) 0.96
Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol (1986) 0.96
Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol (1994) 0.95
Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis (1996) 0.95
Transmission of HIV in prison. BMJ (1993) 0.93
Human cytomegalovirus infection is not increased in common variable immunodeficiency. J Clin Immunol (1996) 0.92
CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection. Pediatr AIDS HIV Infect (1996) 0.91
Prison rights: mandatory drugs tests and performance indicators for prisons. BMJ (1996) 0.91
Mitogenic activation of human lymphocytes: a protein A plaque assay evaluation of polyclonal B-cell activators. Scand J Immunol (1980) 0.90
Mandatory drug tests in prisons. BMJ (1995) 0.90
Study size and documentation to detect injection-related hepatitis C in prison. QJM (1998) 0.89
Benefits of HIV antibody testing in symptom-free risk groups. Lancet (1989) 0.89
Lipopolysaccharide and lipid A-induced human blood lymphocyte activation as detected by a protein A plaque assay. Eur J Immunol (1979) 0.89
Cyclosporin A and Epstein-Barr virus. Lancet (1980) 0.88
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. Br J Cancer (1998) 0.88
Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity. Clin Exp Immunol (1993) 0.87
Severe renal toxicity due to intermediate-dose methotrexate. Cancer Chemother Pharmacol (1989) 0.86
Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B. J Immunol Methods (2000) 0.86
Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children. J Clin Immunol (1994) 0.86
Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte. Clin Exp Immunol (1981) 0.86
Concorde trial of immediate versus deferred zidovudine. Lancet (1994) 0.85
Occupational asthma due to sodium iso-nonanoyl oxybenzene sulphonate, a newly developed detergent ingredient. Thorax (1988) 0.85
AIDS encephalopathy with response to treatment. Arch Dis Child (1988) 0.84
Pulmonary haemosiderosis and gluten. Arch Dis Child (1987) 0.83
Appearance of killer (K) cells in the mesenteric lymph nodes in Crohn's disease. Gastroenterology (1978) 0.83
Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol (1996) 0.83
Prison rites: starting to inject inside. BMJ (1995) 0.83
Reversible acute renal failure precipitated by overdose of ibuprofen and salbutamol. Lancet (1986) 0.82
Long-hours home haemodialysis--the best renal replacement therapy method? QJM (1999) 0.82
B cell differentiation and lymphocyte surface phenotype in late onset hypogammaglobulinaemia. Dis Markers (1990) 0.82
The Edinburgh City Hospital cohort: analysis of enrollment, progression and mortality by baseline covariates. QJM (1995) 0.82
HLA DQ region gene polymorphism associated with primary IgA nephropathy. Kidney Int (1990) 0.82
Dominant inheritance of intracranial berry aneurysm. Br Med J (Clin Res Ed) (1981) 0.82
Lymphocyte subpopulations in early human pregnancy. Obstet Gynecol (1994) 0.81
Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis? Postgrad Med J (1995) 0.81
Extra chromosome 12 in chronic lymphocytic leukaemia. Lancet (1980) 0.80
The relationship between Epstein-Barr virus and lymphoma. Semin Hematol (1982) 0.80
Immunological investigations following an adverse reaction to oxybuprocaine eye drops. Br J Ophthalmol (1999) 0.79
Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis (1997) 0.79
CD8 T lymphocyte subset markers and HIV infection. Clin Exp Immunol (1992) 0.79
Mitogenic stimulation of leukemia cells by Epstein-Barr virus. N Engl J Med (1979) 0.79
Immunoglobulin heavy chain switch region gene polymorphisms in glomerulonephritis. Kidney Int (1990) 0.79
Is there life in the formalin fixed neutrophil for ANCA testing? no! J Clin Pathol (1999) 0.78
The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int (1994) 0.78
How many drug rehabilitation places are needed in prisons to reduce the risk of bloodborne virus infection? Commun Dis Public Health (1999) 0.78
Clinical and epidemiological implications of the Centers for Disease Control/World Health Organization reclassification of AIDS cases. AIDS (1993) 0.78
How necessary are specific IgE antibody tests in allergy diagnosis? Lancet (1983) 0.78
Analysis of blood pressure variability derived from ambulatory blood pressure monitoring in 92 uraemic patients. Contrib Nephrol (1996) 0.77
Treating paracetamol overdose by charcoal haemoperfusion and long-hours high-flux dialysis. QJM (1996) 0.77
Paraproteins in primary biliary cirrhosis. Q J Med (1986) 0.76
HIV infection in women: immunological markers and the influence of pregnancy. AIDS (1995) 0.76
Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities. Ann Rheum Dis (1987) 0.76
Investigation of pulmonary disease in HIV infection. Thorax (1990) 0.75
Unilateral thyroid swelling due to actinomycosis. Postgrad Med J (1986) 0.75
Management of anaphylactic reactions to food. Arch Dis Child (1995) 0.75
Home testing for HIV. Lancet (1994) 0.75
Relation of C reactive protein to cardiovascular risk factors. Assays would have to be developed to measure C reactive protein. BMJ (1996) 0.75
Systemic lupus erythematosus as a cause of the pulmonary renal syndrome. J Intern Med (1996) 0.75
Hyperviscosity syndrome in IgE myeloma. Br Med J (Clin Res Ed) (1984) 0.75
"AIDS" without HIV: fire without smoke. BMJ (1992) 0.75
Acute swollen legs due to rhabdomyolysis: initial management as deep vein thrombosis may lead to acute renal failure. BMJ (1994) 0.75
Vasculitis and rapidly progressive glomerulonephritis in the elderly. Postgrad Med J (1996) 0.75
Pulmonary haemorrhage in Henoch-Schonlein purpura. Thorax (1990) 0.75
A hypogammaglobulinaemic man with respiratory failure. Postgrad Med J (1998) 0.75
Hazards of transmission of HIV during invasive procedures. BMJ (1992) 0.75
Chronic mucocutaneous candidosis in monozygotic twins. J Oral Maxillofac Surg (1987) 0.75
Amino acid dialysate. Contrib Nephrol (1990) 0.75